Thyroid News

Limiting molecular testing to people with thyroid nodules that are Bethesda category III or IV on repeat fine-needle aspiration, or FNA, cytology can reduce the rate of surgery of histologically benign nodules, according to study data.

Most adults with thyroid eye disease receiving an infusion of teprotumumab every 3 weeks for a 24-week period had a reduction of at least 2 mm in proptosis, with a long-term response observed in 67% of participants, according to study data.

Providers should consider clinical context, including comorbidities, when diagnosing and managing thyroid cancer in older adults, according to a study published in Thyroid.

Most physicians treating patients with thyroid cancer said they would suppress thyroid-stimulating hormone in those with low- and intermediate-risk thyroid cancer, according to a study published in Thyroid.

A high human chorionic gonadotropin level in early pregnancy is associated with lower risk for developing gestational diabetes, with maternal free thyroxine level acting as an important mediator, according to data published in Thyroid.

Horizon Therapeutics has received a prior approval supplement for its previously approved biologics license application so that it can manufacture more Tepezza for the treatment of thyroid eye disease, according to a press release.

An updated guideline for best practices in managing anaplastic thyroid cancer stresses the need for patient-centered care, considering disease stage and quality of life before attempting aggressive disease management.

An updated evidence-based guideline supports global neonatal screening for congenital hypothyroidism to optimize detection, diagnosis, treatment and follow-up of children with the condition.

COVID-19 is more severe, with more complications and higher mortality, than influenza among patients with autoimmune disease, according to data published in Rheumatology.

Surveillance after treatment for low-risk thyroid cancer is a balancing act that must consider treatment modality and patient concerns about recurrence, but several considerations can help stratify who should receive follow-up screenings.